Vitiligo Treatment in Cuba: Melagenin Plus® & Placental Histotherapy

Vitiligo is a chronic skin condition characterized by the loss of pigment-producing cells (melanocytes), resulting in white patches on the skin. It affects approximately 1% of the global population and can have significant psychological and social impact. While vitiligo is not life-threatening, its visible nature can cause distress and reduced quality of life.

Cuba has developed unique treatments for vitiligo that are not available in most other countries. The most well-known is Melagenin Plus®, a placental extract-based therapy developed at the Placental Histotherapy Center in Havana. This treatment aims to stimulate repigmentation of affected skin areas.

Cuba's approach to vitiligo treatment combines topical therapy with controlled light exposure (phototherapy), and is delivered by experienced dermatology specialists in specialized clinical facilities. The treatment has attracted international patients from over 60 countries.

Vitiligo presents as depigmented (white) patches on the skin. These patches may appear on any part of the body but are most common on sun-exposed areas (face, hands, arms), body folds (armpits, groin), around body openings (eyes, mouth, nostrils), and on areas with previous injury. The hair in affected areas may also turn white.

Vitiligo is classified into several types: generalized (most common, affecting many body areas), segmental (affecting one side or segment of the body), focal (limited to one or a few areas), and universal (affecting nearly all of the skin). The extent and rate of progression vary widely between individuals.

The condition is believed to be an autoimmune disorder where the immune system attacks and destroys melanocytes. It may be associated with other autoimmune conditions such as thyroid disease, type 1 diabetes, and Addison's disease.

Vitiligo is typically diagnosed through clinical examination by a dermatologist. The diagnosis is based on the characteristic appearance of depigmented patches. A Wood's lamp (ultraviolet light) examination can help highlight affected areas, especially in lighter-skinned individuals.

Additional tests may include blood work to check for associated autoimmune conditions (thyroid function, autoimmune markers), skin biopsy in uncertain cases, and assessment of disease activity to determine whether the vitiligo is stable or actively progressing.

Cuban dermatology specialists perform a thorough assessment to determine the type, extent, and activity of vitiligo, which guides the treatment approach and helps set realistic expectations for repigmentation.

Melagenin Plus® is a topical medication developed at Cuba's Placental Histotherapy Center. It is derived from human placenta and contains a lipoprotein fraction that stimulates melanocyte proliferation and melanin production. The treatment aims to repigment affected skin areas.

Treatment involves daily application of Melagenin Plus® to affected areas, followed by controlled exposure to sunlight or phototherapy. The treatment is painless and non-invasive, making it suitable for patients of all ages and skin types. Treatment cycles typically last several weeks.

Cuba's approach may also include Coriodermina® for related skin conditions and other placental histotherapy products. The dermatology team monitors progress throughout treatment and adjusts the protocol as needed. Best results are typically seen in patients with stable vitiligo affecting limited body areas.

Melagenin Plus® therapy is suitable for most vitiligo patients, including those with generalized, segmental, or focal vitiligo. The treatment tends to be most effective for patients with stable vitiligo (not rapidly progressing) and when treatment is started earlier in the disease course.

Patients with universal vitiligo (near-total depigmentation) may have limited repigmentation potential. A dermatology assessment is required to determine the type, extent, and activity of vitiligo and to set realistic treatment expectations.

To begin the eligibility review, submit photographs of affected areas, dermatologist's report, duration of vitiligo, associated conditions, and current medications through our consultation form.

Vitiligo treatment with Melagenin Plus® typically requires 2–4 weeks in Cuba for the initial treatment cycle, though some patients may benefit from extended or multiple cycles. International patients receive full logistical support including medical visa assistance, airport reception, accommodation, and translation services.

A detailed cost estimate is provided after dermatology review. The program includes dermatology consultations, Melagenin Plus® medication, phototherapy sessions, monitoring, and all logistics. Costs vary based on the extent of affected areas and treatment duration.

Our international patient services team coordinates all arrangements for patients and accompanying family members.